Preparation and Characterization of Nanoparticles for Solubility and Dissolution Rate Enhancement of Meloxicam

The aim of the present work was to enhance dissolut ion of poorly water-soluble meloxicam by preparing stable nanoparticles. Meloxicam nanoparticles were produce by combining antisolvent precipitation and high p ressure homogenization approaches in presence of selected s tabilizers and converting into dry powders by spray -dr ing. The physicochemical properties of drug and its nanopart icles were characterized by SEM, XRD, FT-IR, DSC as well as measuring the particle size and in-vitro drug dissolution. The DSC and XRD results indicat ed hat the antisolvent precipitation process led to the amorphization of m eloxicam. An increase in the stability of the nanop articles was also assured by the sufficient adsorption of the stabili zers onto the drug surface. Meloxicam nanoparticles increased the saturation solubility of drug almost fourfold. The in vitro studies at Q5min showed a marked increase in the drug release from just 7% (raw drug) to 82% (Meloxicam nanoparti cles). The combining of both the methods was a prom ising method to produce uniform and stable nanoparticles of melo xicam with remarkable improvement in dissolution ra te due to an increased solubility by the effect of increased sur face area and change to amorphous form of the drug.

[1]  Jianfeng Chen,et al.  Preparation of uniform prednisolone microcrystals by a controlled microprecipitation method. , 2007, International journal of pharmaceutics.

[2]  Huibi Xu,et al.  A facile nanoaggregation strategy for oral delivery of hydrophobic drugs by utilizing acid–base neutralization reactions , 2008, Nanotechnology.

[3]  Huibi Xu,et al.  Oleanolic acid nanosuspensions: preparation, in‐vitro characterization and enhanced hepatoprotective effect , 2005, The Journal of pharmacy and pharmacology.

[4]  G. Ennas,et al.  Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour. , 2009, International journal of pharmaceutics.

[5]  R. Müller,et al.  Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. , 2001, Advanced drug delivery reviews.

[6]  A. Müllertz,et al.  Adsorption of pharmaceutical excipients onto microcrystals of siramesine hydrochloride: effects on physicochemical properties. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[7]  D. Türck,et al.  Meloxicam oral suspension: a treatment alternative to solid meloxicam formulations , 2001, Inflammation Research.

[8]  P Amsa,et al.  Nanosuspensions: A Promising Drug Delivery Strategy , 2010 .

[9]  Jonathan Brown,et al.  Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches. , 2009, International journal of pharmaceutics.

[10]  Rainer H Müller,et al.  Nanosuspensions: a promising formulation for the new phospholipase A2 inhibitor PX-18. , 2010, International journal of pharmaceutics.

[11]  J Dressman,et al.  Improving drug solubility for oral delivery using solid dispersions. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[12]  M. Fathy Ca-alginate beads loaded with meloxicam: effect of alginate chemical composition on the properties of the beads and ulcerogenicity of the drug , 2006 .

[13]  Sandip S Chavhan,et al.  Nanosuspensions in drug delivery: recent advances, patent scenarios, and commercialization aspects. , 2011, Critical reviews in therapeutic drug carrier systems.

[14]  Ranjita Shegokar,et al.  Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. , 2010, International journal of pharmaceutics.

[15]  M. Mazzotti,et al.  Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability. , 2010, International journal of pharmaceutics.

[16]  J. Hadgraft,et al.  Formation and stabilisation of triclosan colloidal suspensions using supersaturated systems. , 2003, International journal of pharmaceutics.

[17]  Jian Zhang,et al.  Physical and chemical stability of drug nanoparticles. , 2011, Advanced drug delivery reviews.

[18]  Filippos Kesisoglou,et al.  Nanosizing--oral formulation development and biopharmaceutical evaluation. , 2007, Advanced drug delivery reviews.